Oxford Endovascular Ltd.

📍 Oxford, United Kingdom🗓 Founded 2015👥 7 employees💰 Last funded Feb 2021
Medical Equipment Manufacturing🌐 oxfordendovascular.com
Website LinkedIn
Oxford Endovascular is a spin out from Oxford University developing technology to prevent brain haemorrhage. OxiFlow™️ is a novel, next generation flow-diverter, laser-cut from nitinol that diverts blood flow away from intracranial aneurysms at risk of rupture. Competitors have adverse events related to poor placement of devices due to their inherent design weaknesses. OxiFlow™️ is a unique design that places more accurately and safely than existing products, reducing risk of complications and conforms to blood vessel shapes making more patients treatable. Patented in Europe, US, China & Japan. Created by world experts in the field, OxiFlow™ has gone through proof of concept pre-clinical studies that will be followed by a 1st in human study en-route to gaining FDA & CE mark.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Switzerland
1
Frequently asked questions
Who invested in Oxford Endovascular Ltd.?
Oxford Endovascular Ltd. has 2 investors on record on gritt.io and 2 late-stage investors.
When did Oxford Endovascular Ltd. last raise funding?
The most recent investment in Oxford Endovascular Ltd. recorded on gritt.io was in February 2021.
When was Oxford Endovascular Ltd. founded?
Oxford Endovascular Ltd. was founded in 2015.
What industry is Oxford Endovascular Ltd. in?
Oxford Endovascular Ltd. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Oxford Endovascular Ltd. based?
Oxford Endovascular Ltd. is headquartered in Oxford, United Kingdom.